Pangea Bio
PrivateLast Round
Grant
Oct 20, 2025
Total Funding Raised
$16.6M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Pangea Bio is a biotechnology company developing transformative medicines to treat neurological and neuropsychiatric conditions by using AI to unlock nature's neuroactive chemistry.
Sector
Healthcare & Life Sciences
Verticals
Drug Discovery, Biotechnology, Medical AI, Mental Health, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting, Government Contracts
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Pangea Bio Comparables
Compare Pangea Bio with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Sensorium Therapeutics | 88% | |
| Forecast Bio, Inc. | 79% | |
| Montai Health | 77% | |
Pangea Bio Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Oct 20, 2025 | ||||
| Grant | Aug 22, 2024 | ||||
| Accelerator | Mar 5, 2024 |
Key People
Founding team and executive leadership
Pangea Bio Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Playfair Capital | Series A |
| F4 Fund | Series A |
| Metaplanet Holdings | Series A |
| One Mind | Series A, Accelerator |
| Innovate UK | Grant |
| The Michael J. Fox Foundation for Parkinson's Research | Grant, Series A |
| No Label Ventures | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 20, 2026
Open roles increased from 0 to 23, representing 88% of headcount.
- Jan 7, 2026
Monthly visitors increased 59% MoM, reaching 2.4K.
Pangea Bio Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Pangea Bio's valuation, stock price, and market status.